Abstract
Research strategies have been developed to characterize parameters in peripheral tissues that might easily be measured in humans as surrogate markers of damage, dysfunction or interactions involving neural targets of toxicants. The similarities between platelet and neuron may even be clinically important, as a number of biochemical markers show parallel changes in the central nervous system (CNS) and platelets. The purpose of our research was to investigate the effect of Hg2+, Pb2+ and Cd2+ on the [3H]-glutamate binding and [3H]-glutamate uptake in human platelets. The involvement of oxidative stress in the modulation of glutamatergic system induced by heavy metals was also investigated. The present study clearly demonstrates that Hg2+, Cd2+, and Pb2+ inhibited [3H]-glutamate uptake in human platelets. Hg2+ inhibited [3H]-glutamate binding, while Cd2+ and Pb2+ stimulated [3H]-glutamate binding in human platelets. Hg2+, Cd2+ and Pb2+ increased lipid peroxidation levels and reactive oxygen species (ROS) measurement in platelets. The present limited results could suggest that glutamatergic system may be used as a potential biomarker for neurotoxic action of heavy metals in humans.
Similar content being viewed by others
References
Schoepp DD, Con PJ (1993) Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci 14:13–20
Aschner M, Fitsanakis V (2005) The importance of glutamate, glycine, and aminobutyric acid transport and regulation in manganese, mercury and lead neurotoxicity. Toxicol Appl Pharmacol 204:343–354
Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1–105
Rothstein JD, Van Kammen M, Martin L, Levey AL, Kuncl RW (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38:73–84
Rossi DJ, Oshima T, Attwell D (2000) Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403:316–321
Proper EA, Hoogland G, Kappen SM, Jansen GH, Rensen MG, Schrama LH (2002) Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125:32–43
Manzo L, Castoldi AF, Coccini T, Rossi AD, Nicotera P, Costa LG (1995) Mechanisms of neurotoxicity: applications to human biomonitoring. Toxicol Lett 77:63–72
De Gaetano G, Garattino S (1978) Platelets: a multidisciplinary approach. Raven Press, New York
Mangano RM, Schwarcz R (1981) Platelet glutamate and aspartate uptake in Hungtington’s disease. J Neurochem 37:1072–1074
Zoia C, Cogliati T, Tagliabue E, Cavaletti G, Sala G, Galimberti G, Rivolta L, Rossi V, Frattola L, Ferrarese C (2004) Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer’s disease. Neurobiol Aging 25:149–157
Hoogland G, Bos IWM, Kupper F, Spierenburg HA, van Nieuwenhuizen O, de Graan PNE (2005) Thrombin-stimulated glutamate uptake in human platelets is predominantly mediated by the glial glutamate transporter EAAT2. Neurochem Int 47:499–506
Ferrarese C, Zoia C, Pecora N, Piolti R, Frigo M, Bianchi G, Sala G, Begni B, Riva R, Frattola L (1999) Reduced platelet glutamate uptake in Parkinson’s disease. J Neural Transm 106:685–692
Ferrarese C, Begni B, Canevari C, Zoia C, Piolti R, Frigo M, Appollonio L, Frattola L, Mangano RM, Schwarcz R (2000) Glutamate uptake is decreased in platelets from Alzheimer’s disease patients. Ann Neurol 47:641–643
Ferrarese C, Sala G, Riva R, Begni B, Zoia C, Tremolizzo L, Galimberti G, Milul A, Bastone A, Mennini T, Balzarini C, Frattola L, Beghi E (2001) Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology 56:270–272
Nascimento CAM, Nogueira CW, Borges VC, Rocha JBT (2006) Changes in [3H]-glutamate uptake into platelets from patients with bipolar I disorder. Psychiatry Res 141:343–347
Page AL, Al-Amamy MM, Chang AC (1986) Cadmium in the environment and its entry into terrestrial food chain crops. In: Foulkes EC (ed.) Cadmium. Springer, Berlin Heidelberg, New York, pp 33–74
Goering PL, Waalkes MP, Klaassen CD (1995) Toxicology of cadmium. In: Goyer RA, Cherian MG (eds) Handbook of experimental toxicology, vol 115. Springer, Berlin Heidelberg New York, pp 189–213
Minami A, Takeda A, Nishibaba D, Takefuta S, Oku N (2001) Cadmium toxicity in synaptic neurotransmission in the brain. Brain Res 894:336–339
Shukla GS, Singhal RL (1984) The present status of biological effects of toxic metals in the environment: lead, cadmium and manganese. Can J Physiol Pharmacol 62:1015–1031
Wong PCL, Lai JCK, Davinson AN (1981) Selective-inhibition of l-glutamate and gammaaminobutyrate transport in nerve ending particles by aluminum, manganese, and cadmium chloride. J Inor Biochem 14:253–260
Aschner M, Yao CP, Allen JW, Tan KW (2000) Methylmercury alters glutamate transport in astrocytes. Neurochem Int 37:199–206
Atchison WD, Hare MF (1994) Mechanisms of methylmercury-induced neurotoxicity. FASEB J 8:622–629
Yamashita T, Ando Y, Sakashita N, Hirayama K, Tanaka Y, Tashima K, Uchino M, Ando M (1997) Role of nitric oxide in the cerebellar degeneration during methylmercury intoxication. Biochim Biophys Acta 1334:303–311
Juarez BL, Martiez ML, Montante M, Dufour L, Garcia E, Jimenez-Capdeville ME (2002) Methylmercury increases glutamate extracellular levels in frontal cortex of awake rats. Neurotoxicol Teratol 24:767–771
Gong Z, Evans HL (1997) Effect of chelation with mesodimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat. Toxicol Appl Pharmacol 144:205–214
Cory-Sletcha DA (1997) Relationships between Pb-induced changes in neurotransmitter system function and behavioral toxicity. Neurotoxicology 18:673–688
Raulli RE, Jackson B, Tandon N, Mattson M, Rice K, Jamieson GA (1994) Phencyclidine inhibits epinephrine platelet aggregation independently of high affinity N-methyl-D-aspartate (NMDA)- type glutamatereceptors. Biochim Biophys Acta 1224:175–180
Soares FA, Farina M, Santos FW, Souza D, Rocha JBT, Nogueira CW (2003) Interaction between metals and chelating agents affects glutamate binding on brain synaptic membranes. Neurochem Res 28:1859–1865
Trotti D, Nussberger S, Volterra A, Hediger MA (1997) Differential modulation of the uptake in the human neuronal glutamate transporter EAAC1. Eur J Neurosci 9:2207–2212
Trotti D, Rizzini BL, Rossi D, Haugeto O, Racgani G, Danbolt NC, Volterra A (1997) Neuronal and glial transporters possess an SH-based redox regulatory mechanism. Eur J Neurosci 9:1236–1243
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
Lowry OW, Rosenbrough NJ, Farr AL, Randal RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275
Barbeau A, Campanella G, Butterworth RF, Yamada K (1975) Uptake and efflux 14-C- dopamine in platelets: evidence for a generalized defect in Parkinson’s disease. Neurology 25:1–9
Zieve PD, Solomon HM (1968) Uptake of amino acids by the human platelets. Am J Physiol 214:58–61
Sneddon JM (1973) Blood platelets as a model for monoamine-containing neurons. Prog Neurobiol 1:151–198
Franconi F, Miceli M, De Montis MG, Crisafi EL, Bennardini F, Tagliamonte A (1996) NMDA receptors play an antiaggreganting role in human platelets. Thromb Haemost 76:84–87
Skerry TM, Genever PG (2001) Glutamate signaling in non-neuronal tissues. TiPS 22:174–181
Chakrabarti SK, Loua KM, Bai C, Durham H, Panisset J (1998) Modulation of monoamino oxidase activity in different brain regions and platelets following exposure of rats to methylmercury. Neurotoxicol Teratol 20:161–168
Kim P, Choi BH (1995) Selective inhibition of glutamate uptake by mercury in cultured mouse astrocytes. Yonsei Med J 36:299–305
Farina M, Frizzo MES, Soares FAA, Schwalm FD, Dietrich MO, Zeni G, Rocha JBT, Souza DO (2003) Ebseln protects against methylmercury-induced inhibition of glutamate uptake by cortical slices from adult mice. Toxicol Lett 144:351–357
Moretto MB, Funchal C, Santos AQ, Gottfried C, Boff B, Zeni G, Pessoa-Pureur R, Souza DO, Wofchuk S, Rocha JBT (2005) Ebselen protects glutamate uptake inhibition caused by methyl mercury but does not by Hg2+. Toxicology 214:57–66
Yang PT, Ellinor WA, Sather JF, Zhang RW (1993) Molecular determinants of Ca2+ selectivity and ion permeation in L-type Ca2+ channels. Nature 366:109–110
Lasley SM, Gilbert ME (2000) Glutamatergic components underlying lead-induced impairments in hippocampal synaptic plasticity. Neurotoxicology 21:1057–1068
Strusynska L, Chalimoniuk M, Sulkowski G (2005) Changes in expression of neuronal and glial glutamate transporters in lead-exposed adult rat brain. Neurochem Int 47:326–333
Kom JFM, van der Voet GB, Wolff FA (1998) Mercury exposure of maron workers in the small scale gold mining in Suriname. Environ Res 77:91–97
Hirata M, Kosaka H, Yoshida T (2004) A study on the effect of lead on event-related potentials among lead-exposed workers. Ind Health 42:431–434
Acknowledgments
The financial support by UFSM, FAPERGS, CAPES, and CNPq is gratefully acknowledged. J.B.T.R, C.W.N., and F.W.S. are the recipients of CNPq fellowships.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Borges, V.C., Santos, F.W., Rocha, J.B.T. et al. Heavy Metals Modulate Glutamatergic System in Human Platelets. Neurochem Res 32, 953–958 (2007). https://doi.org/10.1007/s11064-006-9231-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-006-9231-7